Beyond Covid-19: What Should MedTech Innovators Expect?

After Covid-19 how will medical device product strategy change? Webinar with medtech commercialization experts

Perspectives on Medical Reimbursement By JR Associates   In recent months, the coronavirus pandemic (Covid-19) has dramatically disrupted businesses around the world. Arguably, healthcare has been more profoundly affected than any other industry. But even as attention remains focused on virus containment and treatment, medical technology companies must prepare for the long-term. “What next?” is…

Read More »

MDMA Reimbursement Conference Notes: 2018

MDMA Reimbursement Conference Notes 2018

Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…

Read More »